<DOC>
	<DOCNO>NCT00584298</DOCNO>
	<brief_summary>This study design provide information feasibility reproducibility barostat assessment colorectal sensory function compliance pharmacological modulation</brief_summary>
	<brief_title>Feasibility Reproducibility Barostat Assessments Colorectal Sensation During Colorectal Distention Its Pharmacological Modulation Using Octreotide</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>A positive diagnosis IBS . Subjects must either surgically sterilize , hysterectomized least 6 month prior screen , postmenopausal use doublebarrier local contraception . Able communicate well investigator , understand comply requirement study . Understand sign write informed consent History evidence structural diseases/conditions affect gastrointestinal system . Other disease condition opinion Investigator significantly affect colorectal sensitivity . Evidence occult blood stool analysis , history rectal bleeding . Using plan use drug agent study period alter GI physiology visceral perception .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Barostat</keyword>
	<keyword>distention</keyword>
	<keyword>IBS</keyword>
	<keyword>irritable</keyword>
	<keyword>bowel</keyword>
	<keyword>syndrome</keyword>
	<keyword>colorectal</keyword>
	<keyword>sensation</keyword>
	<keyword>modulation</keyword>
	<keyword>reproducibility</keyword>
</DOC>